Peptide Atlas · Vitamin

Phytonadione (Vitamin K1)

Newborns are at risk of vitamin K deficiency bleeding in their first six months; under Switzerland's oral vitamin K prophylaxis, nine cases occurred among 505,708 births (2018-2024), all in exclusively breast-fed infants with risk factors such as refused prophylaxis.

established

provisional
PubChem 5284607
2 citations
0 discussions
0 followers
2-methyl-3-phytyl-1,4-naphthoquinone
Phylloquinone
Phytomenadione
Vitamin K1

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- emerging
  Claim: Incidence of anaphylaxis after intravenous phytonadione (retrospective) standing
- resolved
The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review.
Riegert-Johnson DL, Volcheck GW
pmid 12392385
- established
  Claim: Oral neonatal vitamin K prophylaxis in Switzerland: incidence of deficiency bleeding standing
- resolved
Oral neonatal vitamin K deficiency bleeding prophylaxis in Switzerland (2018-2024), still valid guidelines for healthy infants.
Laubscher B, Schubiger G, Rizzi M, Swiss Paediatric Surveillance Unit (SPSU)
pmid 41545738

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.